1. Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon.
- Author
-
Guo, Cuiling, Guo, Dandan, Fang, Liu, Sang, Tingting, Wu, Jianjun, Guo, Chengjie, Wang, Yujie, Wang, Ying, Chen, Chaojie, Chen, Jiajun, Chen, Rong, and Wang, Xingya
- Subjects
- *
GANODERMA lucidum , *GUT microbiome , *CELL physiology , *SHORT-chain fatty acids , *COLORECTAL cancer , *INFLAMMATORY bowel diseases - Abstract
This study investigated the effects of water-soluble polysaccharide extracted from the sporoderm-removed spores of Ganoderma lucidum (GLP) against AOM/DSS-induced inflammation, tumorigenesis, and gut microbiota modification, which has never been reported before. Our data revealed that GLP (200 and 300 mg/kg) decreased AOM/DSS-induced colitis and tumorigenesis, manifested by significantly reduced disease activity index score, and total number and size of tumors. Furthermore, GLP ameliorated AOM/DSS-induced microbiota dysbiosis, increased short-chain fatty acid production, and alleviated endotoxemia by inhibiting TLR4/MyD88/NF-κB signaling. Besides, GLP profoundly improved gut barrier function as evidenced by increased numbers of goblet cells, MUC2 secretion, and tight junction protein expressions. GLP treatment inhibited macrophage infiltration and downregulated IL-1β, iNOS, and COX-2 expressions. Additionally, GLP inhibited lipopolysaccharides (LPS)-induced inflammation markers and MAPK (JNK and ERK) activation in macrophage RAW264.7, intestinal HT-29, and NCM460 cells. In conclusion, these results indicate that GLP is a promising prebiotic for the treatment of colorectal cancer. • GLP inhibits AOM/DSS-induced colitis, inflammation, and tumorigenesis in mice. • GLP improves microbiota dysbiosis and endotoxemia, increases SCFAs production. • GLP improves intestinal barrier function, inhibits immune cell infiltration in mice. • GLP inhibits LPS-induced inflammation in RAW264.7 and intestinal cells. • GLP inhibits TLR4/MyD88/NF-κB and MAPK pathways in vivo and in vitro. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF